Depletion of human serum albumin from plasma samples by immunoextraction on immobilised immuno-affinity CIMmic™
Polyclonal anti-HSA antibodies were immobilised on CIMmic™ HDZ (hydrazide chemistry, 100 μL bed volume), following an optimised protocol. This CIMmic™ α-HSA column was prepared to quantitatively remove human serum albumin (HSA), the most abundant plasma protein in humans, and obtain albumin-free samples which can be further processed.
The CIMmic™ α-HSA column is optimized to selectively bind and remove HSA from plasma; albumins from other sources are bound with low efficiency. HSA depletion is carried out in two steps: (i) a loading step in which the diluted and filtered plasma sample is loaded into the column, HSA is bound and HSA-depleted plasma is collected downstream of the column and (ii) a regeneration step in which the bound HSA is removed and the column is regenerated.